Evaluation of body composition changes, epicardial adipose tissue, and serum omentin-1 levels in overt hypothyroidism

Endocrine

Volumn 49, Issue 1, 2015, Pages 196-203

  Cerit, Ethem Turgay ^a   Akturk, Mujde ^a   Altinova, Alev E ^a   Tavil, Yusuf ^a   Ozkan, Cigdem ^a   Yayla, Cagri ^a   Altay, Mustafa ^a   Demirtas, Canan ^a   Cakir, Nuri ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Body composition; Epicardial adipose tissue; Hypothyroidism; Omentin 1

Indexed keywords

CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADIPOSE TISSUE; ADULT; BLOOD; BODY COMPOSITION; ECHOGRAPHY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PERICARDIUM; PHYSIOLOGY; PROSPECTIVE STUDY;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; LECTINS; MALE; MIDDLE AGED; PERICARDIUM; PROSPECTIVE STUDIES;

EID: 84939945308     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0460-2     Document Type: Article

References (43)

1. G. Huber, J.J. Staub, C. Meier, C. Mitrache, M. Guglielmetti, P. Huber, L.E. Braverman, Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J. Clin. Endocrinol. Metab. 87(7), 3221–3226 (2002)
2. A.P. Weetman, A.M. McGregor, Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15(6), 788 (1994)
3. T. Tzotzas, G.E. Krassas, T. Konstantinidis, M. Bougoulia, Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 10(9), 803–818 (2000)
4. N. Knudsen, P. Laurberg, L.B. Rasmussen, I. Bulow, H. Perrild, L. Ovesen, T. Jorgensen, Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J. Clin. Endocrinol. Metab. 90, 4019–4024 (2005)
5. C.S. Fox, M.J. Pencina, R.B. D’Agostino, J.M. Murabito, E.W. Seely, E.N. Pearce, R.S. Vasan, Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch. Intern. Med. 168(6), 587–592 (2008)
6. A. De Moura Souza, R. Sichieri, Association between serum TSH concentration within the normal range and adiposity. Eur. J. Endocrinol. 165(1), 11–15 (2011)
7. B.O. Asvold, T. Bjoro, L.J. Vatten, Association of serum TSH with high body mass differs between smokers and never-smokers. J. Clin. Endocrinol. Metab. 94(12), 5023–5027 (2009)
8. A. Svare, T.I. Nilsen, T. Bjoro, B.O. Asvold, A. Langhammer, Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway. Clin. Endocrinol. 74(6), 769–775 (2011)
9. J. Westerink, Y. van der Graaf, D.R. Faber, F.L. Visseren, SMART study group, The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease. Eur. J. Clin. Invest. 41(2), 159–166 (2011)
10. B.J. Hoogwerf, F.Q. Nuttall, Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. Am. J. Med. 76(6), 963–970 (1984)
11. J. Karmisholt, S. Andersen, P. Laurberg, Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxedema. J. Clin. Endocrinol. Metab. 96, 99–103 (2011)
12. S. Gjedde, L.C. Gormsen, A.L. Riis, J.O. Jorgensen, J. Rungby, N. Moller, J. Weeke, S.B. Pedersen, Reduced expression of uncoupling protein 2 in adipose tissue in patients with hypothyroidism. J. Clin. Endocrinol. Metab. 95, 3537–3541 (2010)
13. J. Brunova, P. Kasalicky, V. Lansk, The assessment of body composition using DXA in patients with thyroid dysfunction. Cas. Lek. Cesk. 146(5), 497–502 (2007)
14. L. Portmann, V. Giusti, Obesity and hypothyroidism: myth or reality? Rev Med Suisse. 3(105), 859–862 (2007)
15. A.C. Silaghi, L. Poantă, A. Valea, R. Pais, H. Silaghi, Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction? Med Ultrason. 13(1), 15–20 (2011)
16. K. Ueno, T. Anzai, M. Jinzaki, M. Yamada, Y. Jo, Y. Maekawa, A. Kawamura, T. Yoshikawa, Y. Tanami, K. Sato, S. Kuribayashi, S. Ogawa, Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ. J. 73(10), 1927–1933 (2009)
17. Y. Xu, X. Cheng, K. Hong, C. Huang, L. Wan, How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron. Artery Dis. 23(4), 227–233 (2012)
18. M. Asik, S. Sahin, F. Ozkul, I. Anaforoglu, S. Ayhan, S. Karagol, F. Gunes, E. Algun, Evaluation of epicardial fat tissue thickness in patients with Hashimoto thyroiditis. Clin. Endocrinol. 79(4), 571–576 (2013)
19. L. Korkmaz, S. Sahin, A.R. Akyuz, M. Ziyrek, I. Anaforoglu, M. Kose, H. Erkan, M.T. Agac, Z. Acar, Epicardial adipose tissue increased in patients with newly diagnosed subclinical hypothyroidism. Med. Princ. Pract. 22(1), 42–46 (2013)
20. C.M. De Souza Batista, R.Z. Yang, M.J. Lee, N.M. Glynn, D.Z. Yu, J. Pray, K. Ndubuizu, S. Patil, A. Schwartz, M. Kligman, S.K. Fried, D.W. Gong, A.R. Shuldiner, T.I. Pollin, J.C. McLenithan, Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56(6), 1655–1661 (2007)
21. B.K. Tan, R. Adya, H.S. Randeva, Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc. Med. 20(5), 143–148 (2010)
22. H.J. Yoo, S.Y. Hwang, H.C. Hong, H.Y. Choi, S.J. Yang, K.W. Lee, M.S. Nam, Y.S. Park, J.T. Woo, Y.S. Kim, K.M. Choi, S.H. Baik, Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus. Endocrine 44(3), 680–687 (2013)
23. A.R. Cappola, P.W. Ladenson, Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438–2444 (2003)
24. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)
25. G. Iacobellis, F. Assael, M.C. Ribaudo, A. Zappaterreno, G. Alessi, U. Di Mario, F. Leonetti, Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 11(2), 304–310 (2003)
26. G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, F. Leonetti, Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 88, 5163–5168 (2003)
27. N. Chaowalit, V.K. Somers, P.A. Pellikka, C.S. Rihal, F. Lopez-Jimenez, Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 186, 354–359 (2006)
28. M. Bauer, S. Caviezel, A. Teynor, R. Erbel, A.A. Mahabadi, A. Schmidt-Trucksäss, Carotid intima-media thickness as a biomarker of subclinical atherosclerosis. Swiss Med Wkly. 142, w13705 (2012)
29. G. Bartoli, G. Menegaz, M. Lisi, G. Di Stolfo, S. Dragoni, T. Gori, Model-based analysis of flow-mediated dilation and intima-media thickness. Int J Biomed Imaging. 2008, 738545 (2008)
30. C.E. Flodmark, I. Lissau, L.A. Moreno, A. Pietrobelli, K. Widhalm, New insights into the field of children and adolescents’ obesity: the European perspective. Int. J. Obes. Relat. Metab. Disord. 28(10), 1189–1196 (2004)
31. B.J. Strauss, P.R. Gibson, D.B. Stroud, D.J. Borovnicar, D.W. Xiong, J. Keogh, Total body dual X-ray absorbtiometry is a good measure of both fat mass and fat-free mass in liver cirrhosis compared to “gold-standard” techniques. Melbourne Liver Group. Ann. N. Y. Acad. Sci. 904, 55–62 (2000)
32. T. Miazgowski, B. Krzyżanowska-Świniarska, J. Dziwura-Ogonowska, K. Widecka, The associations between cardiometabolic risk factors and visceral fat measured by a new dual-energy X-ray absorptiometry-derived method in lean healthy Caucasian women. Endocrine (2014). doi:10.1007/s12020-014-0180-7
33. T.J. Smith, R.S. Bahn, C.A. Gorman, Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr. Rev. 10, 366–391 (1989)
34. F.W.F. Hanna, M.F. Scanlon, Hyponatraemia, hypothyroidism and role of arginine-vasopressin. Lancet 350, 755–756 (1997)
35. H.S. Sacks, J.N. Fain, T.N. Memphis, Human epicardial adipose tissue: a review. Am. Heart J. 153, 907–917 (2007)
36. H.S. Sacks, J.N. Fain, B. Holman, P. Cheema, A. Chary, F. Parks, J. Karas, R. Optican, S.W. Bahouth, E. Garrett, R.Y. Wolf, R.A. Carter, T. Robbins, D. Wolford, J. Samaha, Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J. Clin. Endocrinol. Metab. 94(9), 3611–3615 (2009)
37. G. Iacobellis, Epicardial adipose tissue in endocrine and metabolic diseases. Endocrine 46(1), 8–15 (2014)
38. G. Iacobellis, E. Lonn, A. Lamy, N. Singh, A.M. Sharma, Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int. J. Cardiol. 146(3), 452–454 (2011)
39. G. Iacobellis, H.J. Willens, G. Barbaro, A.M. Sharma, Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity. 16(4), 887–892 (2008)
40. T. Nagasaki, M. Inaba, Y. Henmi, Y. Kumeda, M. Ueda, H. Tahara, S. Sugiguchi, S. Fujiwara, M. Emoto, E. Ishimura, N. Onoda, T. Ishikawa, Y. Nishizawa, Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin. Endocrinol. 59(5), 607–612 (2003)
41. F. Monzani, N. Caraccio, M. Kozàkowà, A. Dardano, F. Vittone, A. Virdis, S. Taddei, C. Palombo, E. Ferrannini, Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 89, 2099–2106 (2004)
42. J. Lekakis, C. Papamichael, M. Alevizaki, G. Piperingos, P. Marafelia, J. Mantzos, S. Stamatelopoulos, D.A. Koutras, Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid. 7(3), 411–414 (1997)
43. M. Ito, T. Arishima, T. Kudo, E. Nishihara, H. Ohye, S. Kubota, S. Fukata, N. Amino, K. Kuma, I. Sasaki, T. Hiraiwa, T. Hanafusa, J. Takamatsu, A. Miyauchi, Effect of levothyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J. Clin. Endocrinol. Metab. 92, 608–611 (2007)